GlassScriptPhysician profile
Mary Romain
NPI 1598085169
$4,819.03
in general payments reported to CMS, 2019-2025
37 companies · $942 in 2025
The $942 reported for 2025 was more than what 84% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $679 · 2022: $1,654 · 2023: $695 · 2024: $850 · 2025: $942.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,486.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,486.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axonics, INC. | $1,336.56 | 2021-2024 | Axonics |
| Endo Pharmaceuticals INC. | $277.07 | 2021-2024 | Xiaflex, Aveed, Edex |
| Ferring Pharmaceuticals INC. | $266.21 | 2024-2025 | Adstiladrin |
| Boston Scientific Corporation | $250.88 | 2021-2025 | Lithovue |
| Myriad Genetic Laboratories, INC. | $249.49 | 2021-2025 | Prolaris, Myrisk |
| Endo USA, INC. | $230.71 | 2024-2025 | Xiaflex, Aveed |
| Janssen Biotech, INC. | $203.36 | 2022-2025 | Erleada, Akeega, Rybrevant |
| Astellas Pharma US INC | $201.28 | 2021-2023 | Xtandi |
| Merck Sharp & Dohme LLC | $192.32 | 2021-2023 | Lynparza, Keytruda, Welireg |
| Teleflex LLC | $183.40 | 2021-2025 | Urolift, Barrigel |
| Urogen Pharma, INC. | $156.48 | 2022-2025 | Jelmyto |
| Clarus Therapeutics INC. | $136.93 | 2021 | |
| Calyxo, INC. | $112.91 | 2024-2025 | Cvac Aspiration System |
| C. R. Bard, INC. & Subsidiaries | $102.03 | 2024 | Bard Urinary Drainage Bag |
| Sumitomo Pharma America, INC. | $99.36 | 2023-2025 | Gemtesa, Orgovyx |
Show all 37 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mary Romain listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.